Errata (DOI:10.1016/j.transproceed.2006.10.004);Podocin-Related Mechanisms in Posttransplantation Recurrence of Focal Segmental Glomerulsclerosis

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3486-3490

  Caridi, G ^a   Dagnino, M ^a   Sanna Cherchi, S ^a   Perfumo, F ^a   Ghiggeri, G M ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PODOCIN;

ARTICLE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GLOMERULUS FILTRATION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KIDNEY DONOR; MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; SURGICAL PATIENT;

EID: 33845419527     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.01.003     Document Type: Erratum

References (48)

1. Artero M., Biava C., Amend W., et al. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92 (1992) 375
2. Ingulli E., and Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 51 (1991) 401
3. Dall'Amico R., Ghiggeri G., Carraro M., et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34 (1999) 1048
4. Weber S., and Tonshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects. Transplantation 80 (2005) S128
5. Koyama A., Fujisaki M., Kobayashi M., et al. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40 (1991) 453
6. Dantal J., Bigot E., Bogers W., et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330 (1994) 7
7. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334 (1996) 878
8. Sharma M., Sharma R., McCarthy E.T., et al. "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10 (1999) 552
9. Coward R.J., Foster R.R., Patton D., et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16 (2005) 629
10. Musante L., Candiano G., Bruschi M., et al. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2 (2002) 197
11. Sharma R., Khanna A., Sharma M., et al. Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals. Kidney Int 58 (2000) 131
12. Candiano G., Musante L., Carraro M., et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 12 (2001) 143
13. Boute N., Gribouval O., Roselli S., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24 (2000) 349
14. Roselli S., Gribouval O., Boute N., et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160 (2002) 131
15. Schwarz K., Simons M., Reiser J., et al. Podocin, a raft- associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108 (2001) 1621
16. Huber T.B., Kottgen M., Schilling B., et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem 276 (2001) 41543
17. Luimula P., Sandstrom N., Novikov D., et al. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 82 (2002) 713
18. Kawachi H., Koike H., Kurihara H., et al. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 14 (2003) 46
19. Roselli S., Heidet L., Sich M., et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 24 (2004) 550
20. Huber T.B., Simons M., Hartleben B., et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12 (2003) 3397
21. Doublier S., Ruotsalainen V., Salvidio G., et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158 (2001) 1723
22. Doublier S., Salvidio G., Lupia E., et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52 (2003) 1023
23. Koop K., Eikmans M., Baelde H.J., et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14 (2003) 2063
24. Schmid H., Henger A., Cohen C.D., et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 14 (2003) 2958
25. Caridi G., Bertelli R., Carrea A., et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12 (2001) 2742
26. Caridi G., Bertelli R., Di Duca M., et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14 (2003) 1278
27. Caridi G., Bertelli R., Scolari F., et al. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 64 (2003) 365
28. Ruf R.G., Lichtenberger A., Karle S.M., et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15 (2004) 722
29. Weber S., Gribouval O., Esquivel E.L., et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66 (2004) 571
30. Franceschini N., North K.E., Kopp J.B., et al. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8 (2006) 63
31. Caridi G., Perfumo F., and Ghiggeri G.M. NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57 (2005) 54R
32. Koziell A., Grech V., Hussain S., et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 11 (2002) 379
33. Kim J.M., Wu H., Green G., et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300 (2003) 1298
34. Esquivel E.L., Gilbert T., Philippe A., et al. Heterozygous podocin mice spontaneously develop proteinuria and glomerulosclerosis. J Am Soc Nephrol (2004) PO562 (ASN 2004 abstracts)
35. Carraro M., Caridi G., Bruschi M., et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13 (2002) 1946
36. Ghiggeri G.M., Artero M., Carraro M., et al. Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. Nephrol Dial Transplant 16 (2001) 882
37. Vincenti F., and Ghiggeri G.M. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 5 (2005) 1179
38. Bertelli R., Ginevri F., Caridi G., et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41 (2003) 1314
39. Hocker B., Knuppel T., Waldherr R., et al. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 21 (2006) 1476
40. Billing H., Muller D., Ruf R., et al. NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr Nephrol 19 (2004) 561
41. Le Berre L., Godfrin Y., Gunther E., et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 109 (2002) 491
42. Saleem M.A., Ni L., Witherden I., et al. Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol 161 (2002) 1459
43. Doublier S., Musante L., Lupia E., et al. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes. Int J Mol Med 16 (2005) 49
44. Moeller M.J., Sanden S.K., Soofi A., et al. Two gene fragments thatdirect podocyte-specific expression in transgenic mice. J Am Soc Nephrol 13 (2002) 1561
45. Moeller M.J., Sanden S.K., Soofi A., et al. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 35 (2003) 39
46. Rohr C., Prestel J., Heidet L., et al. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 109 (2002) 1073
47. Di Duca M., Oleggini R., Sanna-Cherchi S., et al. Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases. Kidney Int 40 (2006) 1332
48. Oleggini R., Bertelli R., Di Donato A., et al. Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome. Gene Expr 13 (2006) 59